Abstract
Objective. Aortic valve replacement in patients under one year of age remains a pressing challenge in modern cardiac surgery. Valve replacement is either the procedure of choice or a justified necessity in the surgical management of aortic valve pathology in pediatric patients. The absence of small-diameter mechanical prostheses and the complexities of warfarin therapy underscore the relevance of this issue. The aim of this study is to compare the immediate outcomes of the Ross procedure and aortic valve replacement with decellularized pulmonary homograft in infants under one year of age.
Material and methods. A retrospective analysis was conducted of aortic valve replacement outcomes in patients under one year of age at the Federal Center for Cardiovascular Surgery in Krasnoyarsk from September 2013 to December 2024. The study included a total of 18 patients. The study included patients who had undergone the Ross procedure or pulmonary homograft implantation as a method of treating congenital aortic valve defects. Patients with multiple congenital malformations and severe somatic pathology were excluded from the study.
Results. The findings indicate that the compared surgical approaches are equivalent across most analyzed parameters, with the exception of the incidence of postoperative aortic valve insufficiency, which requires further investigation in larger-scale studies. The data suggest comparable safety profiles for the two methods, with no statistically significant differences in most postoperative parameters.
Conclusion. The use of decellularized homografts for aortic valve replacement demonstrates hemodynamic performance comparable to the Ross procedure and represents a promising technique that could replace the Ross procedure in routine practice for aortic valve surgery in infants under one year of age. Reduced cardiopulmonary bypass time and less extensive surgical manipulation of cardiac tissues result in shorter stays in the intensive care unit. The potential for repopulation of homografts with the patient’s own cells and the growth of decellularized homografts may address the issue of valve size mismatch as the child grows, potentially delaying or eliminating the need for reoperation.
References
- Etnel J.R., Elmont L.C., Ertekin E. et al. Outcome after aortic valve replacement in children: A systematic review and meta-analysis. J. Thorac. Cardiovasc. Surg. 2016; 151 (1): 143–52.e1-3. DOI: 10.1016/j.jtcvs.2015.09.083
- Schlein J., Simon P., Wollenek G. et al. Aortic valve replacement in pediatric patients: 30 years single center experience. J. Cardiothorac. Surg. 2021; 16 (1): 259. DOI: 10.1186/s13019-021-01636-2
- Ross D.N. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet. 1967; 2 (7523): 956–958. DOI: 10.1016/s0140-6736(67)90794-5
- Kouchoukos N.T., Dávila-Román V.G., Spray T.L. et al. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N. Engl. J. Med. 1994; 330 (1): 1–6. DOI: 10.1056/NEJM199401063300101
- Karamlou T., Jang K., Williams W.G. et al. Outcomes and associated risk factors for aortic valve replacement in 160 children: a competing-risks analysis. Circulation. 2005; 112 (22): 3462–3469. DOI: 10.1161/CIRCULATIONAHA.105.541649
- Turrentine M.W., Ruzmetov M., Vijay P. et al. Biological versus mechanical aortic valve replacement in children. Ann. Thorac. Surg. 2001; 71 (5 Suppl.): S356–60. DOI: 10.1016/s0003-4975(01)02507-3
- Gerosa G., McKay R., Davies J., Ross D.N. Comparison of the aortic homograft and the pulmonary autograft for aortic valve or root replacement in children. J. Thorac. Cardiovasc. Surg. 1991; 102 (1): 51–60; discussion 60-1.
- Takkenberg J.J., Klieverik L.M., Bekkers J.A. et al. Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study. Eur. J. Cardiothorac. Surg. 2007; 31 (5): 851–859. DOI: 10.1016/j.ejcts.2007.02.009
- Tudorache I., Horke A., Cebotari S. et al. Decellularized aortic homografts for aortic valve and aorta ascendens replacement. Eur. J. Cardiothorac. Surg. 2016; 50 (1): 89–97. DOI: 10.1093/ejcts/ezw013
- D'Udekem Y. Decellularized homografts: in fashion or really superior? Eur. J. Cardiothorac. Surg. 2016; 50 (2): 291–292. DOI: 10.1093/ejcts/ezw068
- Clark J.B., Pauliks L.B., Rogerson A. et al. The Ross operation in children and young adults: a fifteen-year, single-institution experience. Ann. Thorac. Surg. 2011; 91 (6): 1936–1941; discussion 1941–2. DOI: 10.1016/j.athoracsur.2010.12.070
- Bansal N., Kumar S.R., Baker C.J. et al. Age-related outcomes of the ross procedure over 20 years. Ann. Thorac. Surg. 2015; 99 (6): 2077–2083; discussion 2084–5. DOI: 10.1016/j.athoracsur.2015.02.066
- Nelson J.S., Pasquali S.K., Pratt C.N. et al. Long-term survival and reintervention after the ross procedure across the pediatric age spectrum. Ann. Thorac. Surg. 2015; 99 (6): 2086–2094; discussion 2094–5. DOI: 10.1016/j.athoracsur.2015.02.068
- McClure G.R., Belley-Cote E.P., Um K. et al. The Ross procedure versus prosthetic and homograft aortic valve replacement: a systematic review and meta-analysis. Eur. J. Cardiothorac. Surg. 2019; 55 (2): 247–255. DOI: 10.1093/ejcts/ezy247
- Горустович А.В., Линник Ю.И., Евграфова Л.В., Дроздовский К.В. Возможности неокуспидализации аортального клапана у детей. Грудная и сердечно-сосудистая хирургия. 2025; 67 (1): 32–38. DOI: 10.24022/0236-2791-2025-67-1-32-38
- Горустович А.В., Житкова Н.С., Линник Ю.И., Дроздовский К.В. Повторные хирургические вмешательства после операции Росса у детей. Грудная и сердечно-сосудистая хирургия. 2024; 66 (1): 36–42. DOI: 10.24022/0236-2791-2024-66-1-36-42
About the authors
- Egor M. Gvozd, Cardiovascular Surgeon; ORCID
- Pavel V. Teplov, Cardiovascular Surgeon, Head of Department; ORCID
- Aleksander Y. Miller, Cardiovascular Surgeon; ORCID
- Yuliya N. Polyakova, Pediatric Cardiologist; ORCID
- Valeriy A. Sakovich, Dr. Med. Sci., Professor, Cardiovascular Surgeon, Chief Physician; ORCID
- Dmitriy B. Drobot, Dr. Med. Sci., Professor, Cardiovascular Surgeon; ORCID